OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/28/2026
Back to search
Official data from USPTO
NEULOGIQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEULOGIQ
ST13
US500000079411918Class
9, 10, 42, 44
Filing
79411918
Registration
7781412
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
05/29/2026
Trademark type
Word
Nice classes
9, 10, 42, 44
Filing date
05/31/2024
Registration date
05/06/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2025
Last transaction
05/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
24
Owner location
GB
Examiner
GREENE, JOSEPH A
Law office
N70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Cumulus Neuroscience Limited
Representatives
Steven J. Solomon Tucker Ellis LLP
Technical classification
Nice Classes
Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software and computer programs for assessingmonitoringchecking and tracking neurological states and conditionscognitive performancecognitive healthmechanisms of and responses to therapies; electronic scientific laboratory research apparatus and instruments for assessingmonitoringchecking and tracking neurological states and conditionscognitive performancecognitive healthmechanisms of and responses to therapies; downloadable computer games software; downloadable computer software and applications for the provision of medical and pharmaceutical information and reports; downloadable computer software and applications for storingrelayingtrackingmeasuring and displaying the onsetpresence and progression of neurodegenerativeneuropsychiatricneurodevelopmentalneuromuscular and other neurological diseasesas well as brain injuryinsult and mental illness in human beings and other animals; wireless headsets for smartphones and tablet computers; wireless headsets for playing video gamescomputer games and games downloadable on mobile electronic devices; sensors and detectors for scientific use to be worn by a human to gather human biometric data; downloadable computer software and applications for neuroimaging for use in the diagnosis and treatment of medical conditions including neurological diseasebrain injurymental illness; parts and fittings for the aforesaid goods.
Class 10
Medical apparatus and instruments for assessingmonitoringchecking and tracking neurological states and conditionscognitive performancecognitive healthmechanisms of and responses to therapies; medical apparatus and instrumentssensors to be worn by a human for storingrelayingtrackingmeasuring and displaying human cognitive and biometric data; medical apparatus and instruments for storingrelayingtrackingmeasuring the onsetpresence and progression of neurodegenerativeneuropsychiatricneurodevelopmentalneuromuscular and other neurological diseasesas well as brain injury or insult and mental illness in human beings and other animalsfor displaying associated neurological and psychiatric data; medical diagnostic and testing apparatus and instruments for detecting neurological diseasesbrain injuries and mental illnesses; medical apparatus and instrumentselectroencephalogram (EEG) for the therapeutic and medical treatment of disease including neurological diseasebrain injurymental illness; parts and fittings for the aforesaid goods.
Class 42
Design and development of computer software and computer programs for assessingmonitoringchecking and tracking neurological states and conditionscognitive performancecognitive healthmechanisms of and responses to therapies; product developmentdesign and development of electronic apparatus and instruments for assessingmonitoringchecking and tracking neurological states and conditionscognitive performancecognitive healthmechanisms of and responses to therapies; design and development of computer games software; design and development of computer software and mobile and tablet application software for the provision of medical and pharmaceutical information and reports; design and development of computer software and mobile and tablet application software for storingrelayingtrackingmeasuring and displaying the onsetpresence and progression of neurodegenerativeneuropsychiatricneurodevelopmentalneuromuscular and other neurological diseasebrain injury or insult and mental illness in human beings and other animals; product developmentdesign and development of wireless headsets; product developmentdesign and development of wireless headsets for playing video gamescomputer games and games downloadable on mobile electronic devices; product developmentdesign and development of sensors and detectors for scientific use to be worn by a human to gather biometric data; design and development of computer software and mobile and tablet application software for the diagnosis and treatment of medical conditions including neurological diseasebrain injurymental illness; design and development of computer software and mobile and tablet application software for therapeutic and medical treatment of disease including neurological diseasebrain injurymental illness; informationadvisory and consultancy services in relation to the aforesaid services.
Class 44
Medical services; medical screening and testing services; medical evaluation services for neurological diseases; medical examination being health assessment services; neurological and cognitive testing and analysis for medical purposes; medical analysis for the diagnosis and treatment of persons; medical diagnostic services; medical advisory servicesmeasurement and prediction of response to medical treatments; human healthcare servicesneurology and psychiatric healthcare services; medical treatment services of neurological diseasesbrain injuries and mental illnesses; medical diagnostic reporting servicespreparation of reports relating to medical matters; informationadvisory and consultancy services in relation to the aforesaid services.
Publications
History of USPTO decisions and trademark events.
26 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/11/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/11/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/29/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/25/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/05/2025
FIMP
FINAL DISPOSITION PROCESSED
12/05/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/06/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/06/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/18/2025
PUBO
PUBLISHED FOR OPPOSITION
03/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/26/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/24/2025
RFNT
REFUSAL PROCESSED BY IB
01/17/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/31/2024
RFRR
REFUSAL PROCESSED BY MPU
12/31/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/15/2024
CNRT
NON-FINAL ACTION WRITTEN
12/14/2024
DOCK
ASSIGNED TO EXAMINER
12/14/2024
MAFR
APPLICATION FILING RECEIPT MAILED
12/13/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/13/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2024
Continuous trademark protection
Get notified about every new filing that threatens NEULOGIQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.